|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenue | |||
| Cost of revenue (excluding depreciation and amortization) | |||
| Gross profit | |||
| Operating expenses: | |||
| Research and development | |||
| Sales and marketing | |||
| Operations and support | |||
| General and administrative | |||
| Depreciation and amortization | |||
| Total operating expenses | |||
| Operating loss | |||
| Other income (expense), net: | |||
| Interest expense | |||
| Interest income | |||
| Change in fair value of warrant liability | |||
| Warrant expense | |||
| Change in fair value of derivative liability | |||
| Change in fair value of contingent purchase consideration | |||
| Loss on debt extinguishment | |||
| Bargain purchase gain | |||
| Loss on divestiture | |||
| Foreign exchange gain (loss) | |||
| Income from equity method investment | |||
| Other income (expense), net | |||
| Total other expense, net | |||
| Loss before income taxes | |||
| Income tax expense (benefit) | |||
| Net loss attributable to common stockholders | |||
| Other comprehensive income (loss): | |||
| Foreign currency translations adjustments | |||
| Unrealized losses on marketable securities | |||
| Other comprehensive income | |||
| Comprehensive loss | |||
| Loss per share attributable to common stockholders: | |||
| Basic | |||
| Diluted |
Loading...